CELG.RT
Bristol-Myers Squibb Company Contingent Value RightsCELG.RT
CELG.RT
0
Funds holding %
of 7,202 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 20 [Q4 2024] → 20 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.02% less ownership
Funds ownership: 0.05% [Q4 2024] → 0.02% (-0.02%) [Q1 2025]
99% less capital invested
Capital invested by funds: $6.42M [Q4 2024] → $67K (-$6.35M) [Q1 2025]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 0 (-1) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for CELG.RT.
Financial journalist opinion
We haven’t received any recent news articles for CELG.RT.
Charts implemented using Lightweight Charts™